Recombinant DNA Technology Global Market Report 2024

Recombinant DNA Technology Market Report 2023

Recombinant DNA Technology Global Market Report 2024 – By Product Type( Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell and Gene Therapy, Gene Editing ), By Component Type( Expression System, Cloning Vector), By Application Type( Food And Agriculture, Health And Disease, Environment, Other Application Types), By End-Use Type( Biotechnology And Pharmaceutical Companies, Academic And Government Research Institutes, Other End-Use Types) – Market Size, Trends, And Global Forecast 2024-2033

Name: Recombinant DNA Technology Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Recombinant DNA Technology Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 200 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Recombinant DNA Technology Global Market Report 2024

Proud Members Of

Recombinant DNA Technology Market Definition

Recombinant DNA technology refers to fusing DNA molecules from other organisms and inserting those DNA molecules into a host organism to build a new genetic combinations useful for science, medicine, agriculture, and industry. The recombinant DNA technology is used to address health issues by creating new medications and vaccines.

The main product type of recombinant DNA technology include recombinant protein drugs, vaccines, genetically modified crops, expression systems, cell and gene therapy and gene editing. The recombinant protein drugs are used in the biochemical analysis as well as medical diagnostic reagents in human healthcare, such as antibodies, medicines, or vaccines. Recombinant protein drugs are referred to as highly potent medicines that develop faster than small molecules and are safe from off-target negative effects. The component type include expression system and cloning vector. The recombinant DNA technology is applied in food and agriculture, health and disease, environment and other applications and used in biotechnology and pharmaceutical companies, academic and government research institutes and other end-use industries.

Recombinant DNA Technology Market Segmentation

The recombinant dna technology market covered in this report is segmented –

1) By Product Type: Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell and Gene Therapy, Gene Editing

2) By Component Type: Expression System, Cloning Vector

3) By Application Type: Food And Agriculture, Health And Disease, Environment, Other Application Types

4) By End-Use Type: Biotechnology And Pharmaceutical Companies, Academic And Government Research Institutes, Other End-Use Types

Global Recombinant DNA Technology Market Size 2023 to 2028: Graph

Recombinant DNA Technology Market Size 2024 And Growth Rate

The recombinant dna technology market size has grown strongly in recent years. It will grow from $816.9 billion in 2023 to $882.04 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to healthcare demands, biopharmaceutical industry growth, rising investments in r&d, emergence of personalized medicine.

Recombinant DNA Technology Market Growth Forecast

The recombinant dna technology market size is expected to see strong growth in the next few years. It will grow to $1214.85 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to rising chronic diseases, emerging biotech startups, increasing funding in biotech, globalization of biotech markets, consumer acceptance and education. Major trends in the forecast period include scientific advancements, gene editing advancements, cell and gene therapies, development of rna therapeutics, therapeutic applications in rare diseases, ai and data integration.

Book your 30 minutes free consultation with our research experts

Recombinant DNA Technology Market Driver: Rising Prevalence Of Chronic Diseases To Drive Market Growth

The increasing number of chronic diseases is expected to propel the growth of the recombinant DNA technology market. Chronic diseases, which are defined as ailments that last for a year or longer, necessitate continuing medical care, restrict everyday activities, or both. Recombinant DNA technology has improved healthcare by creating biopharmaceuticals proteins used in pharmaceuticals and by replacing defective genes with healthy ones through gene therapy, aiming to cure illness. For instance, in April 2021, according to a report shared by WHO, a Switzerland-based specialized agency of the United Nations responsible for international public health, noncommunicable diseases (NCDs) accounted for 41 million annual deaths, or 71% of all deaths worldwide. Between the ages of 30 and 69, more than 15 million people per year die from an NCD; 85% of these premature deaths take place in low- and middle-income nations. Therefore, the increase in chronic diseases is driving the growth of the recombinant DNA technology market.

Recombinant DNA Technology Market Driver: Rising Development Of Genetically Modified Crops To Drive Market Growth

The increasing development of genetically modified crops is expected to propel the growth of recombinant DNA technology market going forward. Genetically modified crops refer to plants whose genetic makeup has been intentionally altered using biotechnological techniques. Recombinant DNA (rDNA) technology is employed in genetically modified (GM) crops by isolating genes that confer desired traits, constructing recombinant DNA, introducing it into host crop cells, selecting and screening for successful integration, regenerating transgenic plants, testing for trait expression, conducting field trials, obtaining regulatory approval, and ultimately commercializing crops with improved characteristics. For instance, in October 2023, according to United States Department of Agriculture, a US-based government agency, In 2021, herbicide-tolerant (HT) soybean acreage increased to 95 percent, and this percentage remained unchanged in 2023. Additionally, in 2023, 91 percent of domestic corn acres were planted with HT seeds, and 89 percent of U.S. cotton acres utilized genetically engineered, insect-resistant seeds. Therefore, the increasing development of genetically modified crops is driving the growth of recombinant DNA technology market.

Global Recombinant DNA Technology Market Major Players

Major companies operating in the recombinant dna technology market report are Profacgen BioTech Corp., Amgen Inc., Novartis International AG, GenScript Biotech Corporation, Pfizer Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Merck & Co. Inc., Biogen Inc., GlaxoSmithKline plc, New England Biolabs Inc., Bayer CropScience, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc., Gilead Sciences Inc., Moderna Inc., Vertex Pharmaceuticals Incorporated, CRISPR Therapeutics AG, Editas Medicine Inc., bluebird bio Inc., Illumina Inc., Qiagen N.V., Lonza Group AG, Bio-Rad Laboratories Inc., Agilent Technologies Inc., Becton Dickinson and Company, Sartorius AG, Abcam plc, Horizon Discovery Group plc, Integrated DNA Technologies Inc., Twist Bioscience Corporation, Synthego Corporation, Codex DNA Inc., InvivoGen, Eurofins Scientific SE, Sarepta Therapeutics Inc., Sangamo Therapeutics Inc.

Global Recombinant DNA Technology Market Trend: Technological Advancements Driving Innovation In Recombinant Dna Technology Market

Technological advancement is a key trend in the recombinant DNA technology market. Major companies operating in the recombinant DNA technology market are focused on innovative technologies to sustain their position in the market. For instance, in October 2021, Thermo Fisher Scientific, a US-based supplier of scientific instrumentation, reagents and consumables, and software services, introduced the Applied Biosystem QuantStudio Absolute Q-Digital PCR System, the first fully integrated digital PCR (dPCR) equipment made to deliver extremely precise and reliable findings in genetic analysis and research in less than 90 minutes. The QuantStudio Absolute Q System uses microfluidic array technology and streamlined processes instead of the complicated, multi-instrument workflows necessary for standard dPCR, which is intended to increase data accuracy and consistency. The QuantStudio Absolute Q solution is a quick and easy workflow that provides high-quality data with the least amount of manual labour. It combines the data collection, heat cycling, and digitization processes required for dPCR into a single device.

Global Recombinant DNA Technology Market Trend: Product Innovations Transforming The Recombinant Dna Technology Market

Major companies operating in the recombinant DNA technology market are developing new vaccines to sustain their position in the market. For instance, in March 2022, Variation Biotechnologies Inc., a US-based biotechnology company launched PreHevbrio™ [Hepatitis B Vaccine (Recombinant)] in the United States. PreHevbrio received FDA approval in November 2021 and was subsequently added to the ACIP list of recommended adult HBV vaccines in February 2022. Administered as a 3-dose series via intramuscular injection on a 0-, 1-, and 6-month schedule, PreHevbrio contains the essential small (S), middle (pre-S2), and large (pre-S1) hepatitis B surface antigens, ensuring a robust immune response.

Recombinant DNA Technology Market Merger And Acquisition: Thermo Fisher Acquires Peprotech, Boosting Recombinant Proteins And Bioscience Reagent Portfolio

In January 2022, Thermo Fisher Scientific, a US-based scientific instrumentation supplier, reagents, consumables, and software services, acquired PeproTech for $1.85 billion. The acquisition complements Thermo Fisher's cell culture media products with PeproTech's recombinant proteins portfolio, which is expected to allow Thermo Fisher to give customers significant advantages through an integrated offering. PeproTech, Inc. is a US-based developer and manufacturer of bioscience reagents known as recombinant proteins.

Regional Outlook For The Global Recombinant DNA Technology Market

North America was the largest region in the recombinant DNA technology market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the recombinant dna technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the recombinant dna technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The recombinant DNA technology market includes revenues earned by entities by expression systems including mammalian, bacteria, yeast, and baculovirus / insect. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The recombinant DNA technology market research report is one of a series of new reports from The Business Research Company that provides recombinant DNA technology market statistics, including recombinant DNA technology industry global market size, regional shares, competitors with an recombinant DNA technology market share, detailed recombinant DNA technology market segments, market trends and opportunities, and any further data you may need to thrive in the recombinant DNA technology industry. This recombinant DNA technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Recombinant DNA Technology Market Report Forecast And Analysis

Report Attribute	Details
Market Size Value In 2024	$882.04 billion
Revenue Forecast In 2033	$1214.85 billion
Growth Rate	CAGR of 8.3% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Product Type: Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell and Gene Therapy, Gene Editing 2) By Component Type: Expression System, Cloning Vector 3) By Application Type: Food And Agriculture, Health And Disease, Environment, Other Application Types 4) By End-Use Type: Biotechnology And Pharmaceutical Companies, Academic And Government Research Institutes, Other End-Use Types
Regional Scope	Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Profacgen BioTech Corp.; Amgen Inc.; Novartis International AG; GenScript Biotech Corporation; Pfizer Inc.; Novo Nordisk A/S; Eli Lilly and Company; Sanofi S.A.; Merck & Co. Inc.; Biogen Inc.; GlaxoSmithKline PLC; New England Biolabs Inc.; Bayer CropScience; Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche Ltd; Regeneron Pharmaceuticals Inc.; Gilead Sciences Inc.; Moderna Inc.; Vertex Pharmaceuticals Incorporated; CRISPR Therapeutics AG; Editas Medicine Inc.; bluebird bio Inc.; Illumina Inc.; Qiagen N.V.; Lonza Group AG; Bio-Rad Laboratories Inc.; Agilent Technologies Inc.; Becton Dickinson and Company; Sartorius AG; Abcam PLC; Horizon Discovery Group PLC; Integrated DNA Technologies Inc.; Twist Bioscience Corporation; Synthego Corporation; Codex DNA Inc.; InvivoGen; Eurofins Scientific SE; Sarepta Therapeutics Inc.; Sangamo Therapeutics Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Recombinant DNA Technology Market Characteristics

3. Recombinant DNA Technology Market Trends And Strategies

4. Recombinant DNA Technology Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market

4.2. Ukraine-Russia War Impact On the Market

4.3. COVID-19 Impact On the Market

5. Global Recombinant DNA Technology Market Size and Growth

5.1. Global Recombinant DNA Technology Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Recombinant DNA Technology Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Recombinant DNA Technology Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Recombinant DNA Technology Market Segmentation

6.1. Global Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Recombinant Protein Drugs

Vaccines

Genetically Modified Crops

Expression Systems

Cell and Gene Therapy

Gene Editing

6.2. Global Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Expression System

Cloning Vector

6.3. Global Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Food And Agriculture

Health And Disease

Environment

Other Application Types

6.4. Global Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Biotechnology And Pharmaceutical Companies

Academic And Government Research Institutes

Other End-Use Types

7. Recombinant DNA Technology Market Regional And Country Analysis

7.1. Global Recombinant DNA Technology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Recombinant DNA Technology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Recombinant DNA Technology Market

8.1. Asia-Pacific Recombinant DNA Technology Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Recombinant DNA Technology Market

9.1. China Recombinant DNA Technology Market Overview

9.2. China Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Recombinant DNA Technology Market

10.1. India Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Recombinant DNA Technology Market

11.1. Japan Recombinant DNA Technology Market Overview

11.2. Japan Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Recombinant DNA Technology Market

12.1. Australia Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Recombinant DNA Technology Market

13.1. Indonesia Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Recombinant DNA Technology Market

14.1. South Korea Recombinant DNA Technology Market Overview

14.2. South Korea Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Recombinant DNA Technology Market

15.1. Western Europe Recombinant DNA Technology Market Overview

15.2. Western Europe Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Recombinant DNA Technology Market

16.1. UK Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Recombinant DNA Technology Market

17.1. Germany Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Recombinant DNA Technology Market

18.5. France Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.6. France Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.7. France Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Recombinant DNA Technology Market

19.9. Italy Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.10. Italy Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.11. Italy Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Recombinant DNA Technology Market

20.13. Spain Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.14. Spain Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.15. Spain Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Recombinant DNA Technology Market

21.1. Eastern Europe Recombinant DNA Technology Market Overview

21.2. Eastern Europe Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Recombinant DNA Technology Market

22.1. Russia Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Recombinant DNA Technology Market

23.1. North America Recombinant DNA Technology Market Overview

23.2. North America Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Recombinant DNA Technology Market

24.1. USA Recombinant DNA Technology Market Overview

24.2. USA Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Recombinant DNA Technology Market

25.1. Canada Recombinant DNA Technology Market Overview

25.2. Canada Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Recombinant DNA Technology Market

26.1. South America Recombinant DNA Technology Market Overview

26.2. South America Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Recombinant DNA Technology Market

27.1. Brazil Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Recombinant DNA Technology Market

28.1. Middle East Recombinant DNA Technology Market Overview

28.2. Middle East Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Recombinant DNA Technology Market

29.1. Africa Recombinant DNA Technology Market Overview

29.2. Africa Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Recombinant DNA Technology Market Competitive Landscape And Company Profiles

30.1. Recombinant DNA Technology Market Competitive Landscape

30.2. Recombinant DNA Technology Market Company Profiles

30.2.1. Profacgen BioTech Corp.

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. Amgen Inc.

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. Novartis International AG

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. GenScript Biotech Corporation

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. Pfizer Inc.

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Global Recombinant DNA Technology Market Competitive Benchmarking

32. Global Recombinant DNA Technology Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Recombinant DNA Technology Market

34. Recombinant DNA Technology Market Future Outlook and Potential Analysis

34.1 Recombinant DNA Technology Market In 2028 - Countries Offering Most New Opportunities

34.2 Recombinant DNA Technology Market In 2028 - Segments Offering Most New Opportunities

34.3 Recombinant DNA Technology Market In 2028 - Growth Strategies

34.3.1 Market Trend Based Strategies

34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations

35.2. Currencies

35.3. Historic And Forecast Inflation Rates

35.4. Research Inquiries

35.5. The Business Research Company

35.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 6: Global Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 7: Global Recombinant DNA Technology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 8: Global Recombinant DNA Technology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 9: Asia-Pacific, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 10: Asia-Pacific, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 11: Asia-Pacific, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 12: China, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 13: China, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 14: China, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 15: India, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 16: India, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 17: India, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 18: Japan, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 19: Japan, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 20: Japan, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 21: Australia, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 22: Australia, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 23: Australia, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 24: Indonesia, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 25: Indonesia, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 26: Indonesia, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 27: South Korea, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 28: South Korea, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 29: South Korea, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 30: Western Europe, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 31: Western Europe, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 32: Western Europe, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 33: UK, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 34: UK, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 35: UK, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 36: Germany, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 37: Germany, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 38: Germany, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 39: France, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 40: France, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 41: France, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 42: Italy, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 43: Italy, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 44: Italy, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 45: Spain, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 46: Spain, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 47: Spain, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 48: Eastern Europe, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 49: Eastern Europe, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 50: Eastern Europe, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 51: Russia, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 52: Russia, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 53: Russia, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 54: North America, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 55: North America, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 56: North America, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 57: USA, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 58: USA, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 59: USA, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 60: Canada, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 61: Canada, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 62: Canada, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 63: South America, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 64: South America, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 65: South America, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 66: Brazil, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 67: Brazil, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 68: Brazil, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 69: Middle East, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 70: Middle East, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 71: Middle East, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 72: Africa, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 73: Africa, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 74: Africa, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 75: Profacgen BioTech Corp. Financial Performance

Table 76: Amgen Inc. Financial Performance

Table 77: Novartis International AG Financial Performance

Table 78: GenScript Biotech Corporation Financial Performance

Table 79: Pfizer Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2018-2023, $ Billion

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Figure 3: Global Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 4: Global Recombinant DNA Technology Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 5: Global Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 6: Global Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 7: Global Recombinant DNA Technology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 8: Global Recombinant DNA Technology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 9: Asia-Pacific, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 10: Asia-Pacific, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 11: Asia-Pacific, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 12: China, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 13: China, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 14: China, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 15: India, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 16: India, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 17: India, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 18: Japan, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 19: Japan, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 20: Japan, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 21: Australia, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 22: Australia, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 23: Australia, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 24: Indonesia, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 25: Indonesia, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 26: Indonesia, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 27: South Korea, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 28: South Korea, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 29: South Korea, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 30: Western Europe, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 31: Western Europe, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 32: Western Europe, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 33: UK, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 34: UK, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 35: UK, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 36: Germany, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 37: Germany, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 38: Germany, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 39: France, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 40: France, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 41: France, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 42: Italy, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 43: Italy, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 44: Italy, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 45: Spain, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 46: Spain, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 47: Spain, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 48: Eastern Europe, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 49: Eastern Europe, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 50: Eastern Europe, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 51: Russia, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 52: Russia, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 53: Russia, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 54: North America, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 55: North America, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 56: North America, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 57: USA, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 58: USA, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 59: USA, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 60: Canada, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 61: Canada, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 62: Canada, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 63: South America, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 64: South America, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 65: South America, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 66: Brazil, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 67: Brazil, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 68: Brazil, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 69: Middle East, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 70: Middle East, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 71: Middle East, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 72: Africa, Recombinant DNA Technology Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 73: Africa, Recombinant DNA Technology Market, Segmentation By Application Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 74: Africa, Recombinant DNA Technology Market, Segmentation By End-Use Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 75: Profacgen BioTech Corp. Financial Performance

Figure 76: Amgen Inc. Financial Performance

Figure 77: Novartis International AG Financial Performance

Figure 78: GenScript Biotech Corporation Financial Performance

Figure 79: Pfizer Inc. Financial Performance

Global Anesthesia Machines Market 2022 – Market Opportunities And Strategies

Latest Benign Prostatic Hyperplasia BPH Treatment Devices And Equipment Market Growth Study 2022-2026 By The Business Research Company

What Is The Computed Tomography CT Scanners Devices And Equipment Market Overview In 2022?

How Will The Laryngoscope Market Grow In 2022?

The Business Research Company offers the dentures market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the topical drug delivery market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the single-use assemblies market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the neuroscience antibodies and assays market research report 2022 with industry size, share, segments and market growth

Cell Therapy Global Market Report 2024 – By Technique (Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy), By Therapy Type (Allogeneic Therapies, Autologous Therapies), By Application (Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cell Culture Consumables And Equipment Global Market Report 2024 – By Product (Consumables, Instruments), By Application (Vaccination, Toxicity testing, Cancer Research, Drug Screening and Development, Recombinant Products, Stem cell technology, Regenerative Medicine, Other End Users), By End User (Industrial, Biotechnology, Agriculture, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cell Based Assays Global Market Report 2024 – By Product & Service (Consumables, Instruments, Services, Software), By Technology (Automated Handling, Flow Cytometry, Label-Free Detection, High-Throughput Screening, Other Technologies), By Application (Drug Discovery, Basic Research, Adme Studies, Predictive Toxicology, Other Applications), By End User (Pharmaceutical And Biotechnology Companies, Academic And Government Research Institutes, Contract Research Organizations (CRO), Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cellular Telephones Global Market Report 2024 – By Product Type (Smartphone, Feature Phone), By Age-Group (Under 18 Years Old, 18-45 Years Old, 45-60 Years Old, Above 60 Years Old), By Distribution channel (OEM, Retailer, E-commerce) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cell Culture Global Market Report 2024 – By Type (Primary Cell Culture, Secondary Cell Culture, Cell Line), By Media (Natural, Artificial), By Applications (Stem Cell Technologies, Cancer Research, Biopharmaceutical, Tissue Engineering & Regenerative Medicine, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cellular Immunotherapy Global Market Report 2024 – By Therapy (Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy), By Primary Indication (B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma, Other Primary Indications), By Application (Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Other Applications ) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cell and Gene Therapy Global Market Report 2024 – By Product (Cell Therapy, Gene Therapy), By Application (Oncology, Neurological Disorders, Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cellular or Mobile Telephone Services Global Market Report 2024 – By Type (Basic Communication, Value-Added), By Service (3G Services, 4G Services, 5G Services), By End User (Manufacturing, Energy And Utilities, Media And Entertainment, It And Telecom, Transportation And Logistics, Healthcare) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the recombinant DNA technology market?

recombinant DNA technology refers to fusing DNA molecules from other organisms and inserting those DNA molecules into a host organism to build a new genetic combinations useful for science, medicine, agriculture, and industry. The recombinant DNA technology is used to address health issues by creating new medications and vaccines. For further insights on the recombinant DNA technology market, request a sample here

How will the recombinant DNA technology market drivers and restraints affect the recombinant DNA technology market dynamics? What forces will shape the recombinant DNA technology industry going forward?

The recombinant DNA technology market major growth driver - rising prevalence of chronic diseases to drive market growth. For further insights on the recombinant DNA technology market, request a sample here

What is the forecast market size or the forecast market value of the recombinant DNA technology market ?

The recombinant DNA technology market size has grown strongly in recent years. It will grow from $816.9 billion in 2023 to $882.04 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to healthcare demands, biopharmaceutical industry growth, rising investments in r&d, emergence of personalized medicine. The recombinant DNA technology market size is expected to see strong growth in the next few years. It will grow to $1214.85 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to rising chronic diseases, emerging biotech startups, increasing funding in biotech, globalization of biotech markets, consumer acceptance and education. Major trends in the forecast period include scientific advancements, gene editing advancements, cell and gene therapies, development of rna therapeutics, therapeutic applications in rare diseases, ai and data integration. For further insights on the recombinant DNA technology market, request a sample here

How is the recombinant DNA technology market segmented?

The recombinant DNA technology market is segmentedThe recombinant DNA technology market covered in this report is segmented –
1) By Product Type: Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell and Gene Therapy, Gene Editing
2) By Component Type: Expression System, Cloning Vector
3) By Application Type: Food And Agriculture, Health And Disease, Environment, Other Application Types
4) By End-Use Type: Biotechnology And Pharmaceutical Companies, Academic And Government Research Institutes, Other End-Use TypesFor further insights on the recombinant DNA technology market, request a sample here

Which region has the largest share of the recombinant DNA technology market? What are the other regions covered in the report?

North America was the largest region in the recombinant DNA technology market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the recombinant DNA technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the recombinant DNA technology market, request a sample here.

Who are the major players in the recombinant DNA technology market?

Major companies operating in the recombinant DNA technology market report are Profacgen BioTech Corp., Amgen Inc., Novartis International AG, GenScript Biotech Corporation, Pfizer Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Merck & Co. Inc., Biogen Inc., GlaxoSmithKline plc, New England Biolabs Inc., Bayer CropScience, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc., Gilead Sciences Inc., Moderna Inc., Vertex Pharmaceuticals Incorporated, CRISPR Therapeutics AG, Editas Medicine Inc., bluebird bio Inc., Illumina Inc., Qiagen N.V., Lonza Group AG, Bio-Rad Laboratories Inc., Agilent Technologies Inc., Becton Dickinson and Company, Sartorius AG, Abcam plc, Horizon Discovery Group plc, Integrated DNA Technologies Inc., Twist Bioscience Corporation, Synthego Corporation, Codex DNA Inc., InvivoGen, Eurofins Scientific SE, Sarepta Therapeutics Inc., Sangamo Therapeutics Inc. For further insights on the recombinant DNA technology market, request a sample here.

What are the key trends in the recombinant DNA technology market?

Major trend in the recombinant DNA technology market - technological advancements driving innovation in recombinant DNA technology market. For further insights on the recombinant DNA technology market, request a sample here.

What are the major opportunities in the recombinant DNA technology market? What are the strategies for the recombinant DNA technology market?

For detailed insights on the major opportunities and strategies in the recombinant DNA technology market, request a sample here.

How does the recombinant DNA technology market relate to the overall economy and other similar markets?

For detailed insights on recombinant DNA technology market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the recombinant DNA technology industry?

For detailed insights on the mergers and acquisitions in the recombinant DNA technology industry, request a sample here.

What are the key dynamics influencing the recombinant DNA technology market growth? SWOT analysis of the recombinant DNA technology market.

For detailed insights on the key dynamics influencing the recombinant DNA technology market growth and SWOT analysis of the recombinant DNA technology industry, request a sample here.